Abstract: Mitochondria are the major site for the generation of ATP at the expense of molecular oxygen. Significant fractions (~2%) of oxygen are converted to the superoxide radical and its reactive metabolites (ROS) in and around mitochondria. Although ROS have been known to impair a wide variety of biological molecules including lipids, proteins and DNA, thereby causing various diseases, they also play critical roles in the maintenance of aerobic life. Because mitochondria are the major site of free radical generation, they are highly enriched with antioxidants including GSH and enzymes, such as superoxide dismutase (SOD) and glutathione peroxidase, on both sides of their membranes to minimize oxidative stress in and around this organelle. The present work reviews the sites and mechanism of ROS generation by mitochondria, mitochondrial localization of Mn-SOD and Cu,Zn-SOD which has been postulated for a long time to be a cytosolic enzyme. The present work also describes that a cross-talk of molecular oxygen, nitric oxide (NO) and superoxide radicals regulates the circulation, energy metabolism, apoptosis, and functions as a major defense system against pathogens. Pathophysiological significance of ROS generation by mitochondria in the etiology of aging, cancer and degenerative neuronal diseases is also described.
INTRODUCTION
The large amounts of ATP required for the maintenance of aerobic life are generated predominantly by oxidative phosphorylation in mitochondria, a process that results in the conversion of oxygen to the superoxide radical, hydrogen peroxide and related ROS [1] . The enzymes in peroxisomes and microsomes also generate ROS [2] . These hazardous species rapidly react with cellular constituents including lipids, proteins and DNA, thereby modulating or damaging cellular functions [3] [4] [5] . Recent studies [6] revealed that a cross-talk of reactive oxygen and nitrogen species regulates the circulation, energy metabolism, reproduction, embryonic development and remodeling of tissues through apoptotic mechanism, and functions as a major defense system against pathogens. Thus, metabolism of these reactive species should be regulated selectively at or near the sites of their generation. Because mitochondria are the major sites for the generation of ROS, it is important to understand the mechanism by which cells minimize oxidative stress in and around mitochondria. The present work describes the mechanism for the generation of ROS by mitochondria, and the presence of a super system driven by a cross-talk of nitric oxide (NO), superoxide and molecular oxygen that cooperatively regulates the circulation, mitochondrial energy transduction and apoptosis, and functions as a potent defense *Address correspondence to this author at the Department of Biochemistry and Molecular Pathology, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno, Osaka 545-8585, Japan; Tel: +81-6-6645-3720 or 3722; Fax: +81-6-6645-3721; E-mail: inoue@med.osaka-cu.ac.jp mechanism against pathogens. We also describe that oxidative stress in and around mitochondria underlies the pathogenesis of age-associated diseases, such as cancer and neurodegenerative diseases including familial amyotrophic lateral sclerosis (FALS).
MITOCHONDRIAL GENERATION OF ROS
Mitochondria have been known to generate significant amounts of hydrogen peroxide [7, 8] . The amount of its generation differs depending on metabolic state of mitochondria. This activity is higher in State 4 respiration (~1 nmol/min/mg protein) that is defined by a high reduction of the components of the respiratory chains, while it is low in State 3 where the components of electron transfer are largely oxidized. Under physiological conditions, the amount of generation of hydrogen peroxide is estimated to account for about ~2% of the oxygen uptake [9] . Analysis of using specific inhibitors of mitochondria suggested the involvement of a reduced member of the respiratory chain located between the rotenone-and antimycin-sensitive sites in the generation of hydrogen peroxide as the side product of electron transfer reaction. Rotenone has been known to exhibit its cytotoxicity through inhibition of NADH dehydrogenase (complex I) in mitochondrial electron transport chains. It has been practically difficult to detect the occurrence of the superoxide radical in intact mitochondria presumably due to the presence of high activity of SOD. Generation of the superoxide radical by mitochondria was first reported by Loschen et al. [10] . After the determination Fig. (1) . Mechanism of ROS generation by mitochondria.
Mitochondrial production of ROS occurs primarily at two sites, complex I (NADH dehydrogenase) and complex III, a component that forms the Q-b cycle. The electron transport from complex I (NADH dehydrogenase) and complex II (succinate dehydrogenase) to ubiquinone and at complex III is blocked by rotenone, thenoyltrifluoroacetone (TTFA) and antimycin A, respectively. Inhibition of complex IV (cytochrome c oxidase) either by NO, CO or CN causes over flow of free electrons from the respiratory chains, thereby catalyzing the one-electron reduction of molecular oxygen to form the superoxide radical. Superoxide radicals formed on either side of mitochondrial inner membranes are effectively detoxified to hydrogen peroxide and then to water by Cu,Zn-SOD (SOD1) and Mn-SOD (SOD2) and by glutathione peroxidase (GPx), respectively. of the ratios of the mitochondrial generation of superoxide to that of hydrogen peroxide (2.0), the former was considered as a stoichiometric precursor for the latter [11] . Subsequently, ubisemiquinone has been proposed as the main univalent reductant of oxygen in mitochondrial membranes [12] . It has also been found that flavoprotein NADH dehydrogenase is a source for the superoxide generated by bovine heart mitochondria [13] . Flavoproteins acting as electron transferases and dehydrogenases generate stable semiquinone to catalyze the formation of superoxide rather than hydrogen peroxide [14] . Although mitochondria generate the superoxide radical, the amount of its generation by ubisemiquinone-cytochrome b (Q-b cycle) is larger than that by NADH dehydrogenase. Because mitochondria generate 2~3 nmol of superoxide/min per mg of protein, its ubiquitous presence indicates the most important physiological source of this radical and its metabolites in healthy subjects. Figure (1) shows the sites and mechanism of generation of the superoxide radical, hydrogen peroxide and the hydroxy radical in and around mitochondria. These unstable ROS should be safely metabolized at or near the sites of generation due to their hazardous nature.
MITOCHONDRIAL LOCALIZATION OF SOD ISOZYMES
Three types of SOD isozymes, Cu,Zn-SOD, Mn-SOD, and extracellular SOD (EC-SOD) have been known to catalyze the dismutation of the superoxide radical [1] . Whereas Mn-SOD and EC-SOD are localized in the mitochondrial matrix and on the outer surface of cell membranes, respectively, Cu,Zn-SOD has been believed for a long time to reside in cytosol [14] . In the absence of SOD, the superoxide radical is relatively stable, undergoing spontaneous dismutation to form hydrogen peroxide with a life-time of about 5 sec; the rate of this reaction is extremely slow as compared with the SOD-catalyzed dismutation that occurs at a diffusion-limited mechanism (K= 10 9 M -1 s -1 ). Thus, the presence of three types of SOD isozymes suggests that the superoxide radical should be metabolized rapidly at or near the sites of its generation. It should be noted that the viscosity of cytosol enriched with macromolecules and low molecular weight solutes is fairly high and, hence, motional freedom of cytosolic proteins is highly limited. Thus, the collision of enzymes and their substrates in cytosol would occur rather slowly, thereby limiting the rate of enzymatic reactions. Because substantial amounts of superoxide radical is generated on both sides of mitochondrial inner membranes, we hypothesized that Cu,Zn-SOD might also localize bound to mitochondrial membranes thereby facilitating the effective dismutation of this radical. Based on such concept in mind, we reexamined the subcellular localization of Cu,Zn-SOD in rat liver and brain and in human fibroblasts [15, 16] with the use of antibodies specific for Cu,Zn-SOD, Mn-SOD, or PMP-70, a specific marker for peroxisomes [17] . Subcellular fractionation, Nycodenz gradient centrifugation and immunoblot analysis using specific antibodies showed that Cu,Zn-SOD is localized predominantly bound to mitochondria and partly associated with peroxisomes [15, 16] . Immunofluorescence analysis using confocal microscopy revealed that anti-Cu,Zn-SOD antibody in cultured human fibroblasts co-localized predominantly with antibody to Mn-SOD and partly with that to PMP-70 (Fig. 2) . These results indicate that Cu,Zn-SOD associates principally with mitochondria (and partly with peroxisomes) in the brain, liver and skin, and thereby effectively dismutating the superoxide radical on the cytoplasmic surfaces of these organella. Given the relatively long life-time of the superoxide radical and high viscosity of cytosol that restricts the diffusion-limited reaction of the enzyme, it is not surprising that both sides of mitochondrial inner membranes are associated with two SOD isozymes (Fig. 3) . Immunoblot analysis revealed that, although digitonin released Cu,Zn-SOD from mitochondria without affecting the localization of cytochrome c, depolarization of mitochondria by Ca 2+ induced the release of both proteins. Thus, Cu,Zn-SOD seems to localize in the intermembranous space of mitochondria but the nature of its association with the membranes differs from that of cytochrome c [16] . Recent studies also suggested that Cu,Zn-SOD is localized within inter-membranous space of mitochondria [18] .
About 20% of patients with FALS are associated with point mutation of the gene encoding Cu,Zn-SOD; more than 70 different types of mutation of the gene have been reported with FALS. Transgenic mice expressing human type of variant Cu,Zn-SOD also showed motor neuron dysfunctions and the resulting progeny developed clinical signs found in patients with FALS [19, 20] . However, the mechanism by which variant Cu,Zn-SODs cause motor neuron degeneration is largely unknown. To elucidate the role of subcellular localization of Cu,Zn-SOD in the pathogenesis of FALS, we analyzed the association of variant enzymes (G37R, G41S, H46R, N86S, and I113T) to mitochondria and compared with that of the wild-type enzyme. Kinetic analysis revealed that the association of variant Cu,Zn-SODs to mitochondria was decreased significantly as compared with wild-type enzyme. Thus, effective dismutation of the superoxide radical in and around inter-membranous space of cells enriched with mitochondria, such as motor neurons, would be impaired selectively in patients with FALS (Fig. 3) . The replaced amino acids in the FALS-related variant SODs are localized preferentially in the β-barrels of the enzyme that play important roles in the assembly of the two subunits and/or in determining the surface properties of the enzyme [21] . Thus, mutation of the Cu,Zn-SOD gene at different sites might affect the surface properties of the enzyme required for the interaction with mitochondria, thereby increasing the oxidative stress in cells and tissues enriched with mitochondria.
CROSS-TALK OF ROS AND NO REGULATES CIRCULATION AND ENERGY METABOLISM
Nitric oxide functions as an endothelium-derived relaxing factor [22, 23] and regulates intracellular calcium status [24] . Because NO rapidly reacts with oxygen (k = 6 x 10 6 M -2 s -1 ), its lifetime increases significantly under physiologically low oxygen concentrations [25, 26] . Therefore, the change in local oxygen tensions in and around cells might affect biological functions of NO. In fact, the activities of NO to induce arterial relaxation [27] and to inhibit the respiration and ATP synthesis of cells [26] , mitochondria [27] and some bacteria including E. coli [28] markedly increased under physiologically low oxygen tensions (Fig. 4) . When NO inhibited mitochondrial respiration, cellular ATP levels decreased transiently and returned to initial levels soon after the disappearance of its inhibitory effect. Mitochondria regulate cellular calcium homeostasis by an ATP-dependent Superoxide radicals generated within matrix and inter-membranous space of mitochondria are dismutated efficiently at the sites of their generation by Mn-SOD and Cu,Zn-SOD, respectively. The superoxide radical generated by peroxisomes is also dismutated effectively on their cytoplasmic surface. EC-SOD is responsible for the dismutation of extracellular superoxide on cell surface. Mutation of Cu,Zn-SOD found in patients with familiar amyotrophic lateral sclerosis (FALS) markedly decreases the affinity of the enzyme to mitochondria and peroxisomes [15, 16] and causes their aggregation [19] [20] [21] [22] . mechanism. Since NO inhibits mitochondrial ATP synthesis, it increases cytosolic calcium [Ca 2+ ] i particularly under physiologically low oxygen tensions [26] .
Because oxygen concentrations in mitochondria are significantly lower than those in cytosol, NO might affect metabolisms more strongly in the former than in the latter compartment. Kinetic analysis using different respiratory substrates revealed that the reversible inhibition of mitochondrial respiration by NO reflects the inhibition at the site of cytochrome c oxidase. Cytochrome c oxidase is the terminal complex of the mitochondrial respiratory chain responsible for about 90% of oxygen consumption in mammals [29] . The oxidase contains two haems (cyt a and cyt a 3 ) and two copper centers (Cu A and Cu B ). Oxygen binds to the reduced form of a binuclear center consisting of cytochrome a 3 (Fe 2+ ) and Cu B (Cu 1+ ) in the complex. NO binds to the oxygen binding site of the Fe 2+ of cyt a 3 and slowly dissociates from the enzyme [30] [31] [32] [33] [34] [35] [36] . Nitric oxide binds preferentially to the reduced form of Cu B 1+ but also binds to Cu B 2+ to form Cu 1+ -NO + , which is then converted to nitrite [37] . Oxygen binds to the reduced form of binuclear center (Fe 2+ -Cu 1+ ). Thus, binding of NO to the oxidase increases the apparent Km for oxygen [33, 38, 39] . Because two molecules of NO compete with one molecule of oxygen, the IC 50 of NO increases in proportion to the square of the oxygen concentration [40, 41] . The binding of NO to Cu 1+ might be the major pathway for the rapid inhibition of the oxidase.
Because the inhibitory effect of NO on cellular respiration is suppressed significantly by erythrocyte hemoglobin [26] , the biological activities of NO might be stronger in extravascular compartments than in the circulation. In fact, NO derived from inducible NO synthase (iNOS) of peritoneal macrophages strongly inhibited the respiration and ATP-dependent processes of peritoneal tumor cells, such as mitosis and cell growth, particularly under physiologically low oxygen concentrations in the peritoneal cavity [26] . Figure 5 shows the cross-talk of NO, superoxide radical and molecular oxygen that cooperatively regulates the circulation and energy metabolism, and functions as a potent defense mechanism against pathogens and cancer.
ROLE OF MITOCHONDRIAL STRESS IN THE MECHANISM OF APOPTOSIS
It has been known that two major pathways exist for the induction of apoptosis; the one depends on Fas/Fas-ligand system and the other on mitochondrial redox state. Although the mechanism of Fas-mediated apoptosis has been studied Fig. (4) . Oxygen tension regulates biological activities of NO .
Respiration and ATP synthesis (C) by isolated mitochondria, ascites hepatoma AH-130 cells and E. coli were inhibited reversibly by NO; the lower the oxygen tensions the stronger the inhibitory effect. Thus NO functions as a physiological modulator of energy metabolism the potency of which is regulated by local oxygen tensions [25] [26] [27] [28] .
extensively [42] , that induced by mitochondria remains to be elucidated. Mitochondria-dependent apoptosis is associated with the generation of ROS [43] . Although the two mechanisms have been known to mediate apoptosis by different pathways, they interact with each other. In fact, TNFα has been shown to activate ROS generation by mitochondria. Anti-apoptotic protein Bcl-2 protects cells from apoptosis under conditions that ROS generation is suppressed. Superoxide generation by mitochondria is enhanced in apoptotic cells due to switching from the normal 4-electron reduction of oxygen to its one-electron reduction particularly when cytochrome c is released from the inter-membranous space to cytosol. The switch in electron transfer provides a mechanism for redox signaling to elicit cytochrome c-dependent activation of caspases. A variety of mitochondrial poisons are known to stimulate ROS generation by a mechanism that involves inhibition of electron transfer, accumulation of reducing equivalents in electron transfer chains, and direct one-electron transfer to molecular oxygen (see Fig. 1 ).
Among various factors, NO is one of the important endogenous metabolites that enhances the generation of RSO. Nitric oxide interacts with the terminal oxidase [44] and enhances the generation of superoxide and related metabolites, that increases the intracellular free calcium ion [Ca 2+ ] i and activate Ca 2+ -dependent phospholipase A 2 , thereby enhancing the opening of membrane permeability transition (MPT) pores (Fig. 6) . Accumulation of Ca 2+ in mitochondria triggers a number of events leading to nonspecific increase in inner membrane permeability [45] . Studies using electron spin resonance method revealed that formation of Ca 2+ -cardiolipin complex plays an important role in the sequestration of this lipid tightly bound to ADP-ATP carrier and other membranous proteins to form immobilized lipid clusters within inner membranes [46] . In the presence of Ca 2+ , cardiolipin induces hexagonal H II phase transition of a bilayer, thereby causing lateral phase separation of membrane/lipid bilayers [47] . Such a rearrangement of membranous proteins and lipids in the inner membranes induced by Ca 2+ causes multimembrane dysfunction to enhance the release of free electrons to generate ROS. Because cardiolipin contains highly unsaturated, oxidation prone, acyl chains, tight packing of cardiolipin in the Ca 2+ -induced clusters might provide an environment that is favorable for faster propagation of the radical chain reaction. In fact, Ca 2+ induces ROS generation, thereby enhancing oxidation of proteins and lipid of mitochondria [45, 48] . Nitric oxide increases oxygen delivery to tissues by inducing vasorelaxation, but inhibits electron transport and ATP synthesis in mitochondria and aerobic bacteria predominantly by interacting with their terminal oxidases. Lowering oxygen tensions increased the activities of NO. Inhibition of electron transport releases free electrons and increases the generation of the superoxide that rapidly reacts with NO. Such a pivotal action of NO and the cross talk of the three radicals constitute a super system that cooperatively regulates the circulation and energy metabolism, and functions as defense mechanism against pathogens.
Fig. (6). Mitochondrial generation of ROS and regulation of apoptosis.
Overproduction of superoxide radicals either by complex I or Q-b cycle increases oxidative stress, causes oxidation of the critical thiol groups of ANT to induce membrane permeability transition (MPT), thereby releasing cytochrome c and/or SOD1 from inter membranous space of mitochondria to induce apoptosis. Such a sequence of events can be triggered by NO and calcium overload by a mechanism which could be inhibited by carnitine and targeting SOD to the injured tissues. ANT, adenine nucleotide translocase; VDAC, voltage-dependent anion channel; CsA, cyclosporin A; CypD, cyclophilin D; PLA2, phospholipase A2; FFAs, free fatty acids. Because NO depolarizes the membrane potential, elevates the cytosolic Ca 2+ , and releases cytochrome c, it might trigger the sequence of cellular events leading to apoptosis [49, 50] . Similar changes in mitochondria are also induced by various ligands that release cytochrome c and apoptosisrelated proteins, thereby determining death and survival of cells in various tissues [51] . Release of cytochrome c from mitochondria can be mediated by adenine nucleotide translocase (ANT) via a Ca 2+ -mediated mechanism. It should be noted that such an increase in [Ca 2+ ] i is not always the consequence of mitochondrial dysfunction. In this context, Rakhit et al [52] reported that preconditioning of cardiomyocytes by NO induced mitochondrial depolarization but protected cells from anoxic injury. Brown and Brown [53] also reported that NO induces three types of reaction of mitochondria, reversible inhibition of their respiration, stimulated generation of superoxide, hydrogen peroxide and peroxynitrite, and irreversible inhibition followed by induction of mitochondrial MPT. In some cases, inhibition of mitochondrial respiration induces either necrosis or apoptosis by activating the mitochondrial pathway to induce MPT. Because mitochondrial release of apoptosis-related proteins can be triggered by functional and/or structural modifications of ANT and voltagedependent anion channel (VDAC) in their membranes by a variety of ligands, enhanced release of free electrons followed by generation of the superoxide radical by NO might facilitate the sequence of events leading to apoptosis. In fact, Chang, et al [54] showed that mice lacking iNOS show strong resistance to anti-Fas antibody-induced fulminant hepatitis. When the amount of ROS generation reached to some threshold, mitochondrial stress starts to catalyze the oxidation of the critical thiol groups in ANT to induce MPT, a prerequisite reaction to cytochrome c release, thereby triggering cytosolic cascades of caspases leading to apoptosis (Fig. 6) .
MITOCHONDRIA AS A POTENTIAL TARGET FOR CHEMOTHERAPY
Although hazardous free radicals underlie the mechanism of carcinogenesis, they also play important roles in the treatment of patients with cancer, such as radiation and chemotherapy. Because the use of anticancer agents is highly limited due to their strong side effects in normal tissues, its inhibition without suppressing their tumoricidal activities is important. Because cis-diaminedichloro-platinum (cisplatin) preferentially accumulates in the kidney and gastrointestinal tracts and generates ROS in and around mitochondria, it exhibits strong side effects in these tissues. The administered cisplatin rapidly accumulated in the kidney and intestine, oxidatively impaired mtDNA, decreased mitochondrial functions, induced apoptosis of epithelial cells, and finally caused severe nephropathy and gastrointestinal dysfunction. In fact, suppression of oxidative stress by hexamethylene-diamine-conjugated SOD that rapidly accumulates in renal proximal tubule cells, and selectively dismutates the superoxide radical strongly inhibited the side effects of cisplatin specifically in the kidney [55, 56] .
Kinetic analysis revealed that the nephrophilic SOD inhibited the cisplatin-induced mtDNA injury, mitochondrial dysfunction, cytochrome c release and tubule cell apoptosis (Fig. 7) , thereby exhibiting renal dysfunction (Fig. 8) . Thus, the superoxide radical generated in and around renal tubule cells might play critical roles in the pathogenesis of cisplatin-induced nephropathy. This SOD derivative also inhibited cisplatin nephropathy without suppressing the tumoricidal activity of this drug and significantly improved the survival of tumor-bearing animals [56] . Thus, the nephrophilic SOD and related antioxidants may have therapeutic potential in inhibiting the renal toxicity of anticancer agents.
We also found that free forms of long chain fatty acids released by Ca 2+ -activated phospholipase A 2 perturbed membrane/lipid bilayers of mitochondria, thereby enhancing the oxidative injury of mitochondria to induce MPT, a prerequisite to cytochrome c release and apoptosis (see Fig.  6 ). Because L-carnitine forms conjugates with long chain fatty acids and enhances β-oxidation to generate ATP, it may suppress the fatty acid-induced mitochondrial dysfunction and apoptosis. Thus, the protective effects of carnitine against cisplatin might be expected in the kidney and small intestine that are highly enriched with OCTN2, a specific transporter for carnitine [57] . In fact, oral administration of carnitine strongly inhibited the cisplatin-induced injury and apoptosis in the kidney (Figs. 7, 8 ) and small intestine and suppressed the increase in plasma BUN and creatinine and the occurrence of diarrhea and intestinal mucosal atrophy [58] . Because of potent side effects of cisplatine in the kidney and small intestine, the motality of cancer-bearing animals increased markedly after treating animals with this anticancer agent. In contrast, the motality decreased markedly when the animals were orally administered carnitine (Fig. 9 ) . Thus, site-specific protection of mitochondria and mtDNA from hazardous anticancer agents Fig. (9) . L-carnitine increased the survival of cisplatin-treated cancer-bearing animals.
The survival of cancer-bearing rats (A) was decreased by administration of cisplatin alone (B) but increased when co-administered with L-carnitine (C). Other conditions were the same as in Fig. (5) .
by targeting SOD and/or carnitine may have therapeutic potential in patients with cancer to minimize the side effects of anticancer agents without decreasing their tumoricidal activity.
OXIDATIVE INJURY OF mtDNA IN THE LIVER OF PATIENTS WITH CHRONIC HEPATITIS AND CANCER
Because large amounts of reactive oxygen and nitrogen species are generated by activated leukocytes, inflammation is one of the major causes that impairs cellular constituents including DNA. Oxidative modification of DNA causes mutation that underlies the mechanism of carcinogenesis. In fact, the incidence of cancer significantly increases in patients with chronic hepatitis and ulcerative colitis [59] . Persistent infection with hepatitis B or C virus ultimately results in the development of hepatocellular carcinoma, the process of which is fairly rapid in individuals with chronic viral hepatitis. Generation of ROS is markedly enhanced by inflammatory reactions in the liver of individuals infected with hepatitis viruses [60] , and oxidative stress is a potent inducer of DNA mutations [61] . Treatment of patients with chronic hepatitis using interferon reduces the incidence of hepatocellular carcinoma. Thus, chronic inflammation induced by hepatitis viruses thus plays important roles in hepatocarcinogenesis. Immunohistochemical and biochemical analysis revealed a marked expression of iNOS in hepatocytes with a diffuse lobular pattern in all liver samples from patients with viral hepatitis [62] . The presence of a substantial amount of nitrotyrosyl proteins suggests the occurrence of both NO and superoxide radicals that cause oxidative injury of proteins and DNA during the course of long-lasting inflammation.
Mutations in mtDNA accumulate more easily than in nuclear DNA [63] . Because the expression of the entire genome of mitochondria is necessary for the maintenance of their functions, small changes in mtDNA sequence might result in profound impairment of their functions. Mt-DNA harboring certain mutations might generate abnormal RNAs and/or proteins, the latter of which may promote leakage of electrons from the mitochondrial electron transport chains. The amounts of endogenously produced ROS might thus be increased in cells with mutant mtDNA. The resulting oxidative modification of DNA therefore may contribute to the initiation and/or promotion of carcinogenesis. Therefore, we hypothesized that chronic inflammation might increase oxidative stress to stimulate mitochondrial generation of ROS, thereby enhancing the mutation of mtDNA and nuclear DNA to increase the risk of cancer. Analysis of the mtDNA in cancerous and non-cancerous regions of the liver of individuals with hepatocellular carcinoma revealed that the mtDNA sequence from the liver of the control subjects contained three single-base mutations in the D-loop, while those from the cancerous tissues contained numerous mutations, more than half of which were apparent in the mtDNA from the paired non-cancerous liver specimens (Fig.  10) [59] . Histochemical examination revealed that protein carbonyls and nitrotyrosine-residues were apparent in the liver specimens of patients with chronic hepatitis and cancer, suggesting the occurrence of NO and ROS. Presumably due to severe and long lasting inflammation, ROS and NO generated in the liver impaired mitochondria and other constituents in hepatocytes. Oxidative injury of mitochondria might enhance the release of ROS to induce enhanced mutation of mtDNA might result in the formation of defective proteins in the electron transport chains and increase the generation of ROS, thus forming vicious cycle for free radical injury of mitochondria and nucleus finally to result in the formation of liver cancer.
The high frequency of mtDNA mutations in noncancerous liver tissues of patients with chronic hepatitis suggests that their hepatocytes rapidly reach the initial stage of malignant transformation during the inflammation. Most of mtDNA mutations detected were homoplasmic in nature, indicating that the mutated mtDNA had become dominant in both cancer cells and hepatocytes in non-cancerous regions of the inflammatory liver. Given the clonal nature and large number of copies of mtDNA, mutation of the mitochondrial genome in non-cancerous regions in the liver of patients with chronic hepatitis is indicative of genomic instability and likely contributes to the hepatocarcinogenesis.
Consistent with this hypothesis is our findings that the mutation of mtDNA in the liver specimens from patients with chronic viral hepatitis was strongly inhibited by successful treatment with interferon for several years [64] . In contrast, the mtDNA specimens from patients who failed to respond to interferon treatment showed significant mutation within several months. Thus, protection of mitochondria and mtDNA in the liver by antioxidants and related biomodulators might have therapeutic potential in patients with chronic viral hepatitis and cancer. Because similar mechanism seems to underlie the pathogenesis of other types of cancer associated with chronic inflammation, such as ulcerative colitis [64] , antioxidant therapy should also be examined in cancer patients associated with chronic inflammation. Cancers occurring based on chronic inflammation may thus be defined as a mitochondrial disease.
